Litcius/Paper detail

Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer

Antonino Musolino, Daniela Boggiani, Benedetta Pellegrino, Daniele Zanoni, Angelica Sikokis, Gabriele Missale, Enrico Maria Silini, Giuseppe Maglietta, Antonio Frassoldati, Maria Michiara

2020Critical Reviews in Oncology/Hematology21 citationsDOIOpen Access PDF

Topics & Concepts

TrastuzumabMonoclonal antibodyAcquired immune systemInnate immune systemImmunityImmunologyBreast cancerAntibodyMedicineAcquired resistanceCancerImmune systemInternal medicineMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune ResponsesHER2/EGFR in Cancer Research
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer | Litcius